COTEAU Get App

UNIT

Uniti Group Inc.
$5.51
+1.29% 2026-10-20
Communication ServicesS&P 600
-5%+28%+61%+94%+128%Oct 2025Apr 2026Oct 2026
UNITSPY
1W
-17.1%
1M
-41.7%
3M
-50.2%
6M
-53.0%
YTD
-21.4%
1Y
-1.6%

Live chart

Loading live chart…

What they do

Uniti Group Inc. a digital infrastructure company in the United States. The company operates through three segments: Kinetic, Uniti Solutions, and Fiber Infrastructure. The Kinetic segment offers internet services, local and long-distance voice services, integrated voice and data services, and web conferencing products.

Real Estate · REIT - Specialty

Grades vs sector

Momentum
92nd pct in sector
A
12-1 return: +45.5%
Percentile within its GICS sector across the S&P 1500.
Growth
100th pct in sector
A+
Revenue growth (YoY): +202.5%
Percentile within its GICS sector across the S&P 1500.
Value
73rd pct in sector
B+
Forward E/P: – · EBITDA/EV: 12.2%
Percentile within its GICS sector across the S&P 1500.
Profitability
88th pct in sector
A-
Profit margin: +30.4% · Return on equity: –
Percentile within its GICS sector across the S&P 1500.
Revisions
Not enough data yet
–
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Our models

Not held by any of our 5 live models right now.

Quality Growth
not ranked (outside this model's universe or screens)
Momentum Top 15
not ranked (outside this model's universe or screens)
Momentum Blend
not in the current book
New Highs Growth
not ranked (outside this model's universe or screens)
Conviction 20
not in the current book

News

More news
TechnipFMC, BP Unit Sign MoU on 20,000-PSI Subsea Tree Systems for Paleogene Projects
MT Newswires · 19h ago
Tropical Smoothie Cafe Signs 40-Unit Deal in New York and Connecticut
QSR · 19h ago
SpaceX tops quarterly revenue estimates as AI unit surges
Proactive · 20h ago
First Horizon Unit Collaborates With Greenlight to Offer Family Finance App, Safety Tools
MT Newswires · 21h ago
Abbott Laboratories' Established Pharma Unit Undervalued on Biosimilars Potential, UBS Says
MT Newswires · Oct 20

Key stats

Market cap$1.3B
P/E (trailing)3.5
P/E (forward)-7.8
52-week range5.39 – 12.94
Revenue growth (YoY, latest qtr)+202.5%
Dividend yield0.00%
Analyst consensusHold (8)
Mean price target$10.78 (+96%)
Valuation and fundamentals

Valuation & fundamentals

Bottom line
Leans undervalued
Model read-out from the numbers below, not advice. Score +1 (DCF counts double).
▲DCF (base case)above the price by 960%
•Piotroski F-score5/9
▼Altman Z0.4 (distress)
▼Net debt / EBITDA8.2x
▲Analyst target+96% (8 analysts)

Discounted cash flow

Bear
$5
-7%
growth 18% · disc. 12.4% · term. 2.0%
Base
$58
+960%
growth 30% · disc. 11.4% · term. 2.5%
Bull
$135
+2348%
growth 38% · disc. 10.4% · term. 3.0%

A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.

Reverse DCFfor context, not a signal
Today's price assumes free cash flow grows about 12% a year for 10 years.
Implied
+12%/yr
FCF, last 3 yrs
n/a
FCF, last 5 yrs
n/a
Revenue, last 3 yrs
n/a
Revenue, last 5 yrs
n/a
Same inputs as the DCF above: trailing free cash flow 0.5B, 11.4% discount rate, 2.5% growth after year 10, net debt and today's share count. Actual growth rates are compound annual rates from SEC annual filings through FY2025; "n/a" means too little history or a negative starting year.
Edit assumptions · recalculates instantly
Your value per share–

Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.43 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.

Multiples vs Communication Services

P/E (trailing)
sector median 18.8× · 3rd pct
3.5×
cheaper
Forward P/E
sector median 11.0×
–
EV / EBITDA
sector median 12.2× · 33rd pct
9.3×
cheaper
Price / sales
sector median 1.9× · 2nd pct
0.4×
cheaper
Price / book
sector median 2.3× · 80th pct
8.3×
pricier
FCF yield
sector median 8.2% · 93rd pct
37.8%
cheaper

Forward EPS $-0.71 vs trailing $1.56 (-146% expected growth). Forward P/E uses analysts' next-12-month estimate.

Backlog (remaining performance obligations)

RPO
$2.1B
as of 2026-06-30
vs a year ago
–
YoY
× TTM revenue
0.59×
coverage
25-09
25-12
26-03
26-06

Contracted revenue not yet recognized, from SEC filings (XBRL tag RevenueRemainingPerformanceObligation).

Quality & financial health

Gross margin
–
Operating margin
3.2%
FCF margin
14.3%
Net margin
30.4%
Return on equity
666.9%
Return on invested capital
0.9%
Net debt / EBITDA
8.2×
Current ratio
1.2×
Interest cover
0.2×
Cash conversion (OCF/NI)
0.5×
Piotroski F-score 5/9 · last two fiscal years
✓ Positive net income✓ Positive operating cash flow✓ Return on assets improved✗ Cash flow above net income✓ Long-term debt / assets fell✓ Current ratio improved✗ No share dilution✗ Gross margin improved✗ Asset turnover improved

Altman Z-score 0.4 (distress zone; above 3.0 = safe, below 1.8 = distress). Not meaningful for banks and insurers.

Analysts

Mean target
$11
+96%
Analysts
8
Hold
Range
$7–$16
low – high
● price · ◆ mean target

Annual history

FYRevenueNet incomeFree cash flow
2025$2.2B$1.3B$350.2M
2024$1.2B$93.4M$366.6M
2023$1.1B$-81.7M$353.2M

From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR –.

Earnings

Next report: 2026-11-09 · before open · EPS est -0.58
24-1025-0225-0525-0725-1126-0326-0526-07-1.190.17
EstimateActual (beat)Actual (miss)
ReportEPS estActualSurprise
2026-07-30-0.48-0.68-41.1%
2026-05-11-0.34-0.34+1.2%
2026-03-02-0.36-1.19-228.0%
2025-11-04-0.010.11+1234.9%
2025-07-31-0.56-0.02+97.3%
2025-05-060.090.08-11.8%
2025-02-210.170.15-11.9%
2024-10-310.160.08-47.2%

Quarterly revenue

QuarterRevenueYoY
2026-06-30$909.7M+202.5%
2026-03-31$987.5M–
2025-12-31$917.2M–
2025-09-30$722.6M–
2025-06-30$300.7M–
Analyst actions
JP Morgan
2026-07-31 · main
Neutral → Neutral
PT $11
TD Cowen
2026-07-31 · main
Buy → Buy
PT $11
Barclays
2026-07-01 · main
Equal-Weight → Equal-Weight
PT $13
Citigroup
2026-05-19 · main
Neutral → Neutral
PT $12
TD Cowen
2026-05-12 · main
Buy → Buy
PT $12
JP Morgan
2026-05-12 · main
Neutral → Neutral
PT $12

Recent dividends

2024-06-14: $0.249 · 2024-03-27: $0.249 · 2023-12-14: $0.249 · 2023-09-07: $0.249 · 2023-06-15: $0.249 · 2023-03-30: $0.249 · 2022-12-15: $0.249 · 2022-09-08: $0.249
Insider trades
None
None · None
SELL
–
None
None · None
SELL
–
None
None · None
SELL
–
None
None · None
SELL
–

Stats refreshed 2026-10-20 18:03:16 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

COTEAU

Coteau Systematic Strategies publishes stock research and model portfolios. It doesn't manage money or give investment advice. Results are hypothetical unless marked Live. Data: Yahoo Finance (delayed) and SEC EDGAR.